Randomized controlled trials remain the most effective tool in the pharmaceutical industry’s evidence-generation toolkit. They are crucial for demonstrating novel drugs' safety and efficacy, assessing ...

Although all authors completed the disclosure declaration, the following author(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article.

"Just saying the same thing over and over again, whether in social media or in medical literature, ain’t gonna get it done."- ...

A phase 2 trial of androgen deprivation therapy interruption in patients responding exceptionally to androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM / ...